60 Degrees Pharmaceuticals (SXTP) Tax Provisions (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Tax Provisions of -$1813.0 for Q4 2025, up 99.89% year-over-year from -$906.99 in Q4 2024, and down 825.2% quarter-over-quarter from $250.0 in Q3 2025.
60 Degrees Pharmaceuticals (SXTP) Tax Provisions (2022 - 2025) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Tax Provisions for 4 consecutive years, with -$1813.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions rose 99.89% year-over-year to -$1813.0; the TTM figure through Sep 2025 stood at -$1.7 million (down 205712.68% YoY), while the FY2024 annual figure was -$1.7 million, down 668354.8% from the prior year.
- Tax Provisions fell to -$1813.0 in Q4 2025 per SXTP's latest filing, from $250.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1500.0 in Q2 2025 and bottomed at -$1.7 million in Q4 2024.
- Historically, Tax Provisions has averaged -$197857.8 across 4 years, with a median of $63.0 in 2023.
- On a YoY basis, Tax Provisions climbed as much as 595.24% in 2024 and fell as far as 2740080.33% in 2024.
- 60 Degrees Pharmaceuticals' Tax Provisions stood at -$1.3 million in 2022, then jumped by 100.0% to $61.0 in 2023, then plunged by 2740080.33% to -$1.7 million in 2024, then surged by 99.89% to -$1813.0 in 2025.
- Business Quant data shows SXTP's Tax Provisions at -$1813.0 in Q4 2025, $250.0 in Q3 2025, and $1500.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,813.00 |
| Sep 30, 2025 | 250.00 |
| Jun 30, 2025 | 1,500.00 |
| Mar 31, 2025 | 63.00 |
| Dec 31, 2024 | -1.67 Mn |
| Sep 30, 2024 | 250.00 |
| Jun 30, 2024 | 438.00 |
| Mar 31, 2024 | 63.00 |
| Dec 31, 2023 | 61.00 |
| Sep 30, 2023 | 63.00 |
| Jun 30, 2023 | 63.00 |
| Mar 31, 2023 | 63.00 |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | 250.00 |
| Jun 30, 2022 | 250.00 |